HitGen (SHSE:688222) Total Operating Expense: ¥166.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688222 HitGen Inc SHSE:688222
90 GF Score
Price ¥28.60
GF Value ¥26.07
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is HitGen Total Operating Expense?

HitGen SHSE:688222 +1.06% 90 Total Operating Expense is ¥166.0 Mil as of Mar. 2026. GuruFocus rates SHSE:688222 with a GF Score™ of 90/100 and a GF Value™ of ¥26.07 (Fairly Valued). The stock has 1 warning sign investors should review.

HitGen's Total Operating Expense for the three months ended in Mar. 2026 was ¥40.7 Mil. HitGen's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ¥166.0 Mil.

HitGen Total Operating Expense Related Terms

HitGen Total Operating Expense Historical Data

* Premium members only.

The historical data trend for HitGen's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HitGen Total Operating Expense Chart

HitGen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 111.03 162.16 148.56 134.88 152.24

HitGen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.97 33.19 34.56 57.52 40.72
SHSE:688222
90GF Score
HitGen Inc SHSE:688222
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HitGen Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥166.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ¥166.0 Mil mean?
HitGen (SHSE:688222) has a Total Operating Expense of ¥166.0 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on HitGen and its competitors.
Is HitGen's Total Operating Expense too high?
HitGen's current Total Operating Expense is ¥166.0 Mil. Overall, HitGen has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HitGen's Total Operating Expense compare to VRTX and REGN?
HitGen's Total Operating Expense of ¥166.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on HitGen and its competitors. HitGen's current Total Operating Expense is ¥166.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HitGen stock overvalued right now?
Based on GuruFocus' analysis, HitGen (SHSE:688222) is currently considered Fairly Valued. The stock's GF Value™ is ¥26.07, compared to a current price of ¥28.60 — trading 9.7% above its estimated fair value. The current Total Operating Expense is ¥166.0 Mil. HitGen's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For HitGen (SHSE:688222), the current Total Operating Expense is ¥166.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HitGen (SHSE:688222) Overvalued in 2026?

Based on GuruFocus' analysis, HitGen stock appears to be overvalued. The current stock price of ¥28.60 is trading 9.7% above its estimated GF Value™ of ¥26.07. GuruFocus considers HitGen to be Fairly Valued.

Key valuation signals for SHSE:688222:

  • Total Operating Expense: ¥166.0 Mil
  • GF Value™: ¥26.07 vs. price of ¥28.60 (9.7% above fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the SHSE:688222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HitGen Business Description

Address Section 2, Biocity Middle Road, Chengdu Tianfu International Biological City, No. 18, Shuangliu District, Sichuan Province, Chengdu, CHN, 610093
HitGen Inc is dedicated to building a world-class biopharmaceutical enterprise. Its mission is to advance human health and quality of life. It provides therapeutic solutions to address unmet medical needs. Centered on its internationally DEL (DNA-encoded Library) technology, the Company has expanded into Fragment-Based Drug Discovery and Structure-Based Drug Design and a suite of complementary platforms based on Oligonucleotide-based Therapeutics, Targeted Proximity Drugs, and Cyclic Peptidomimetics. The group has developed HAILO, a proprietary "DEL+AI+Automation" molecular optimization platform, thereby establishing a distinctive novel molecule discovery engine that delivers both therapeutic molecules and tool molecules to the world-wide pharmaceutical industry.
90GF Score

Get the complete analysis for SHSE:688222

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.60
Price
¥26.07
GF Value